Grifols Sa revenue for the last year amounted to 7.28 B USD, the most of which — 6.13 B USD — came from its highest performing source at the moment, Biopharma, the year earlier bringing 5.36 B USD. The greatest contribution to the revenue figure was made by United States and Canada — last year it brought Grifols Sa 4.30 B USD, and the year before that — 4.13 B USD.